According to BCC Research, Single-Use Technology for Biopharmaceuticals will Reach $3 Billion Globally in 2020

June 12, 2015

Wellesley, Mass., June 12, 2015 – Single-use systems address specialized needs by reducing capital costs of drugs and their time-to-market. Research and development spending, increasing competition and new technologies are all serving to give the market new impetus according to BCC Research’s latest report on single-use technologies for the biopharmaceutical market. The global market reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is anticipated to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3 billion for the period 2014-2019.

Single-use technologies can be applied to upstream as well as downstream bioprocessing, from formulation to filling. These technologies are used in the production of all types of biopharmaceuticals. Changes in lifestyles and healthcare systems, and increasing demand for drugs at reduced prices, has led to the development of facilities that can produce more than one product, offering flexibility and scalability.

“Single-use/disposable technology has emerged over the past decade as a cost-effective and flexible basis for biopharmaceutical manufacturing. The biopharmaceutical industry is rapidly adopting single-use technology for clinical trials, product launches and commercial production of biomolecules to provide cost-effective and flexible process capabilities,” says BCC Research analyst Shalini S. Dewan. “These technologies have requirements, advantages and disadvantages that differ from traditional reusable technology.”

Single-Use Technologies for Biopharmaceuticals: Global Markets(BIO099B) offers a view on the necessity of implementing single-use techniques from the perspective of quality product development. This study looks at the growth of single-use technology equipment manufacturers and users. Pharmaceutical, biotechnical companies and research institutes will find this study to be of interest.

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at

Single-Use Technologies for Biopharmaceuticals: Global Markets( BIO099B )
Publish Date: May 2015    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email or visit to request access to our library of market research.